Circulating levels of brain-derived neurotrophic factor: correlation with mood, cognition and motor function.
about
Neuroplasticity and the next wave of antidepressant strategiesEndurance Exercise as an "Endogenous" Neuro-enhancement Strategy to Facilitate Motor LearningBiomarkers of postoperative delirium and cognitive dysfunctionMild cognitive impairment. Part 2: Biological markers for diagnosis and prediction of dementia in Alzheimer's diseaseThe Analysis of Two BDNF Polymorphisms G196A/C270T in Chinese Sporadic Amyotrophic Lateral Sclerosis.Contribution of neural cell death to depressive phenotypes of streptozotocin-induced diabetic mice.Rapid antidepressant changes with sleep deprivation in major depressive disorder are associated with changes in vascular endothelial growth factor (VEGF): a pilot studyThe effect of recombinant erythropoietin on plasma brain derived neurotrophic factor levels in patients with affective disorders: a randomised controlled study.Relationship between Sonic hedgehog protein, brain-derived neurotrophic factor and oxidative stress in autism spectrum disordersPlasma biosignature and brain pathology related to persistent cognitive impairment in late-life depression.Expression of monoamine transporters, nitric oxide synthase 3, and neurotrophin genes in antidepressant-stimulated astrocytesMood Disorders and BDNF Relationship with Alcohol Drinking Trajectories among PLWH Receiving Care.Brain-derived neurotrophic factor genetic polymorphism (rs6265) is protective against chemotherapy-associated cognitive impairment in patients with early-stage breast cancer.Pilot Study and Review: Physiological Differences in BDNF, a Potential Biomarker in Males and Females with Autistic Disorder.Molecular and neural bases underlying roles of BDNF in the control of body weight.Cognitive impairment in Huntington disease: diagnosis and treatment.Brain-derived neurotrophic factor plasma levels are associated with mortality in critically ill patients even in the absence of brain injury.Cortical Amyloid β Deposition and Current Depressive Symptoms in Alzheimer Disease and Mild Cognitive Impairment.Agomelatine Increases BDNF Serum Levels in Depressed Patients in Correlation with the Improvement of Depressive Symptoms.Serum levels of brain-derived neurotrophic factor correlate with the number of T2 MRI lesions in multiple sclerosis.Brain-derived neurotrophic factor levels in late-life depression and comorbid mild cognitive impairment: a longitudinal study.Brain-derived neurotrophic factor and Alzheimer's disease: physiopathology and beyond.Novel biomarkers for bipolar disorder.Challenges of Huntington's disease and quest for therapeutic biomarkers.Biomarkers and staging of bipolar disorder: a systematic review.Peripheral blood brain-derived neurotrophic factor in bipolar disorder: a comprehensive systematic review and meta-analysis.Measuring myokines with cardiovascular functions: pre-analytical variables affecting the analytical output.Update on bipolar disorder biomarker candidates.Lower Cerebrospinal Fluid Concentration of Brain-Derived Neurotrophic Factor Predicts Progression from Mild Cognitive Impairment to Alzheimer's Disease.Treatment Emergent Suicidal Ideation in depressed older adults.FunMod: a Cytoscape plugin for identifying functional modules in undirected protein-protein networks.Brain-Derived Neurotrophic Factor, Depression, and Physical Activity: Making the Neuroplastic Connection.Serum brain-derived neurotrophic factor levels in different neurological diseases.Evaluation of plasma brain-derived neurotrophic factor levels and self-perceived cognitive impairment post-chemotherapy: a longitudinal study.Seeking an objective diagnosis of depression.Walking speed decline in older adults is associated with elevated pro-BDNF in plasma extracellular vesicles.Decreased plasma neurotrophin-4/5 levels in bipolar disorder patients in mania.TNFR1 absence protects against memory deficit induced by sepsis possibly through over-expression of hippocampal BDNF.Participation of the neutrophin brain-derived neurotrophic factor in neuropsychiatric systemic lupus erythematosus.Platelet GSK3B activity in patients with late-life depression: marker of depressive episode severity and cognitive impairment?
P2860
Q21129480-261343C2-BCB0-47EA-B435-9C5911D318F0Q26772814-D99FD2FA-9707-43ED-A400-FEB0CF83674EQ26830796-5794ED31-CA7D-40C5-BA0A-53061E4F7233Q27027319-E9BE225C-C62A-41D7-9DE2-3C1F207A6F3FQ33653823-75B2AFE2-017C-4B5F-890D-D4B63C397F80Q33677254-0F3A5989-C49B-4F79-924D-C7E25F3B9F1FQ34630614-5945DFB6-D0A8-4ABB-8D2B-03FB6CBAECF0Q35642010-B793D083-3553-4435-9479-B6E3D13703E3Q35691058-FA52E1AF-34D1-41FE-9175-FAEFD3E4E168Q35828096-C194D920-8214-4DB1-837D-A2C59F5FDB9FQ35899423-9008F29A-1775-4EE5-A007-631E86200A63Q36181723-2F1C3843-313A-49D3-B63F-701B36754685Q36493824-AF9B8DC5-D28C-461E-A692-461B7CE1B2BAQ36558162-50FE0AC8-4ACB-406A-A1F0-152B06238AD4Q36705780-59D3AE24-2C6D-4990-9DED-FD57BECC52A4Q36773397-863CC389-2517-4E25-95E8-E33FFBF9104CQ36902843-EC2C5639-1917-4F32-813B-2F4227C75B5EQ36910036-92666BEE-84EF-4CCA-AF60-85798CE6247AQ36950592-EAF8E7D9-F212-4652-9FA7-ACB7BFD48663Q37370757-94B90823-3FDF-4E1C-A0F0-5E44C29642D8Q37579433-29CE7C54-7FB5-463B-9097-D94E70068E32Q37928495-493C23F6-B773-450A-B79C-3AB364455A37Q38093255-C0162B41-6C71-4F6A-9AA0-DA4654B48ADEQ38257697-84196CC0-BB0F-4B50-A069-6F7DA057111AQ38414455-5CF128C4-95F9-490F-97B5-7774195EE27FQ38550939-EEC2FF4C-1552-4F13-B14E-B3449CA9D690Q38601292-62E1BD9A-37E0-48A2-BAC1-21A3D3D7BEDAQ38803583-77FB74EE-9AC5-4A46-A0B6-A7A4B7B29393Q38988833-73A1B110-03EF-4476-92BB-182318453860Q39780546-59F7D45A-E521-4468-AC55-7BD8CA0224C6Q39992601-33FA89EB-DC99-4F7A-BAD2-0C548FDF775BQ41452493-C7CCC6CC-054D-4F17-AF54-1F2FB3FCA1D5Q41811172-81FAA408-6D9F-4B64-9998-838F1583A514Q47134578-5349FD16-4736-4045-BEFE-FEE32F32B8EEQ48048867-81F0F7B2-11C6-4E86-8A06-A75D351A28B3Q48138848-BFADBA81-9E45-41DB-A036-76F0D06EE4B6Q48244131-38714FDF-F809-45E4-8DBD-9B66600BA759Q48590246-3E7516BA-0A5A-451D-B51A-E9B12FFE13B8Q48709210-CFA67938-41E9-49E5-BCDA-5401C4F7E63FQ48912689-8DDB042B-A1AE-447C-88B3-30BC99A97257
P2860
Circulating levels of brain-derived neurotrophic factor: correlation with mood, cognition and motor function.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Circulating levels of brain-de ...... cognition and motor function.
@en
Circulating levels of brain-de ...... cognition and motor function.
@nl
type
label
Circulating levels of brain-de ...... cognition and motor function.
@en
Circulating levels of brain-de ...... cognition and motor function.
@nl
prefLabel
Circulating levels of brain-de ...... cognition and motor function.
@en
Circulating levels of brain-de ...... cognition and motor function.
@nl
P2860
P50
P356
P1476
Circulating levels of brain-de ...... , cognition and motor function
@en
P2093
Izabela Guimarães Barbosa
P2860
P304
P356
10.2217/BMM.10.111
P577
2010-12-01T00:00:00Z